康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09966 康宁杰瑞制药-B

未开盘 04-10 16:08:18

5.930

+0.150

+2.60%

最高6.360	最低5.850	成交量345.00万
今开6.130	昨收5.780	日振幅8.82%
总市值57.05亿	流通市值57.05亿	总股本9.62亿
成交额2,096万	换手率0.36%	流通股本9.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":5.93,"timestamp":1744272498022,"preClose":5.78,"halted":0,"volume":3450000,"delay":0,"floatShares":961999999,"shares":961999999,"eps":0.1837074502722999,"marketStatus":"未开盘","change":0.15,"latestTime":"04-10 16:08:18","open":6.13,"high":6.36,"low":5.85,"amount":20963070,"amplitude":0.088235,"askPrice":5.97,"askSize":1000,"bidPrice":5.93,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.18066275154768743,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744335000000},"marketStatusCode":0,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":5.78,"openAndCloseTimeList":[[1744248600000,1744257600000],[1744261200000,1744272000000]],"volumeRatio":0.6486730405770519,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"2518471626","title":"康宁杰瑞制药-B03月11日主力净流入109万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518471626?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:15","pubTimestamp":1741680935,"startTime":"0","endTime":"0","summary":"03月11日, 康宁杰瑞制药-B股价涨4.65%，报收5.18元，成交金额2218万元，换手率0.45%，振幅7.88%，量比0.40。康宁杰瑞制药-B今日主力资金净流入109万元，上一交易日主力净流出363万元。该股主力净额占比0.02%，港股市场排名289/2656。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165452a1d49be2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165452a1d49be2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2518151750","title":"康宁杰瑞制药-B盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518151750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518151750?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:12","pubTimestamp":1741659134,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘10时12分，康宁杰瑞制药-B股票出现异动，股价急速上涨5.05%。截至发稿，该股报5.200港元/股，成交量78.8万股，换手率0.08%，振幅6.87%。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为1.05%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司高度差异化的内部管线由处于不同研发阶段的肿瘤单克隆抗体、双特异性抗体及ADCs组成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311101214a26bd322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311101214a26bd322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2518324680","title":"康宁杰瑞制药-B03月10日主力净流出363万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518324680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518324680?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:17","pubTimestamp":1741594649,"startTime":"0","endTime":"0","summary":"03月10日, 康宁杰瑞制药-B股价跌18.45%，报收4.95元，成交金额5300万元，换手率1.06%，振幅15.98%，量比1.00。康宁杰瑞制药-B今日主力资金净流出363万元，上一交易日主力净流入269万元。该股近5个交易日下跌7.48%，主力资金累计净流入863万元；近20日主力资金累计净流入3186万元，其中净流入天数为14日。该股主力净额占比0.08%，港股市场排名2558/2655。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170927a269bec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170927a269bec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2518825678","title":"港股异动 | 康宁杰瑞制药-B(09966)早盘跌超14% 公司遭剔出港股通名单 此前预计首次实现年度盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2518825678","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518825678?lang=zh_cn&edition=full","pubTime":"2025-03-10 09:54","pubTimestamp":1741571672,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康宁杰瑞制药-B早盘跌超14%，截至发稿，跌12.85%，报5.29港元，成交额1712.59万港元。消息面上，2月21日，恒生指数有限公司宣布季度检讨结果，康宁杰瑞制药-B遭剔除出恒生综合指数。3月10日，深交所公告，港股通标的证券名单发生调整并自2025年03月10日起生效，康宁杰瑞制药-B遭剔除港股通名单。值得注意的是，康宁杰瑞制药拟于3月25日举行董事会会议批准年度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4614","09966","BK1161","HSCEI","BK1574","YANG"],"gpt_icon":0},{"id":"2518258529","title":"深交所发布关于深港通下的港股通标的证券名单调整的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258529","media":"深交所网站","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518258529?lang=zh_cn&edition=full","pubTime":"2025-03-10 08:58","pubTimestamp":1741568314,"startTime":"0","endTime":"0","summary":"因恒生综合大型股指数、中型股指数、小型股指数实施成份股定期调整,根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2025年03月10日起生效，相关调整信息如下：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02407","01268","00659","03309","06639","02582","02522","02121","00095","09959","BK1240","00697","03939","01119","02678","02506","02461","02460","00999","02487","01468","02510","06698","09869","01318","01600","HSTECH","01541","BK1582","HSCEI","02577","02507","02423","02411","BK1555","09985","02432","02232","02105","06660","02570","09966","02586","02562","02799","06623","01799","01942","02410","02587","00410","00041","02171","02431","03669","02150","03650","00743","00308"],"gpt_icon":0},{"id":"2518425923","title":"沽空预警榜 | 3月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2518425923","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518425923?lang=zh_cn&edition=full","pubTime":"2025-03-09 02:15","pubTimestamp":1741457700,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为15.87%，过去两个月大市日均沽空比例为17.21%。其中，PP中新经济、PP国债对冲-U、PP中新经济-U沽空比率排名前三位，分别为100.00%、100.00%、100.00%。阿里巴巴-W、恒生中国企业、南方恒生科技的沽空金额排名前三位，分别为67.15亿、62.37亿、44.84亿。科笛-B、宜明昂科-B、XL二博时中创业的偏离值排名前三位，分别为6.58、4.48、4.25。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/09021548611902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HXXD.SI","81211","89618","09807","BYDDY","81024","03337","HMTD.SI","00700","03033","80700","02487","09195","07266","HK0000306685.HKD","09173","03173","01033","002594","HBBD.SI","02800","01541","BK1586","02883","89988","02828","BABA","HYDD.SI","TCEHY","BK4548","07332","09966","HTCD.SI","02807","09988","81810","09177","LU2045819591.USD","02829","03050","07234"],"gpt_icon":1},{"id":"2517910513","title":"康宁杰瑞制药-B03月07日主力净流入269万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910513?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:16","pubTimestamp":1741335419,"startTime":"0","endTime":"0","summary":"03月07日, 康宁杰瑞制药-B股价涨4.66%，报收6.07元，成交金额5022万元，换手率0.88%，振幅7.59%，量比0.78。康宁杰瑞制药-B今日主力资金净流入269万元，上一交易日主力净流出431万元。该股近5个交易日上涨3.40%，主力资金累计净流入1357万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2894万元，其中净流入天数为14日。该股主力净额占比0.05%，港股市场排名173/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170906abecc9cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170906abecc9cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2517121638","title":"康宁杰瑞制药-B盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517121638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517121638?lang=zh_cn&edition=full","pubTime":"2025-03-07 13:14","pubTimestamp":1741324486,"startTime":"0","endTime":"0","summary":"2025年03月07日下午盘13时14分，康宁杰瑞制药-B股票出现波动，股价急速拉升5.00%。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为0.37%。消息层面，截至13时14分，《康宁杰瑞制药绩后大涨！首次实现年度盈利》资讯为影响康宁杰瑞制药-B的重要信息。康宁杰瑞制药绩后大涨超10%，领涨恒生医药ETF持仓股，再鼎医药、巨子生物、诺诚健华等涨幅靠前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307131446963d06dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307131446963d06dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2517813936","title":"康宁杰瑞制药-B03月06日主力净流出431万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517813936?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:15","pubTimestamp":1741248935,"startTime":"0","endTime":"0","summary":"03月06日, 康宁杰瑞制药-B股价跌4.13%，报收5.80元，成交金额4912万元，换手率0.86%，振幅7.27%，量比0.51。康宁杰瑞制药-B今日主力资金净流出431万元，上一交易日主力净流入1438万元。该股近5个交易日下跌4.61%，主力资金累计净流入468万元；近20日主力资金累计净流入2781万元，其中净流入天数为14日。该股主力净额占比0.08%，港股市场排名2579/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165315a262285c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165315a262285c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2517186283","title":"康宁杰瑞制药-B盘中异动 下午盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517186283?lang=zh_cn&edition=full","pubTime":"2025-03-06 14:58","pubTimestamp":1741244288,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时58分，康宁杰瑞制药-B股票出现波动，股价快速下挫5.29%。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为0.47%。消息层面，截至14时58分，《康宁杰瑞制药绩后大涨！首次实现年度盈利》资讯为影响康宁杰瑞制药-B的重要信息。康宁杰瑞制药绩后大涨超10%，领涨恒生医药ETF持仓股，再鼎医药、巨子生物、诺诚健华等涨幅靠前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306145809a261f929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306145809a261f929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2517953044","title":"【港股异动丨康宁杰瑞制药大涨超15% 料首次实现年度盈利】康宁杰瑞制药-B(9966.HK)盘中一度涨超15%，报6.05港元。消息面上，集团发盈喜，预计2024年度利润不少于1.5亿人民币，首次实现年度盈利，主要基于三项授权合作和销售收入。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517953044","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517953044?lang=zh_cn&edition=full","pubTime":"2025-03-05 11:12","pubTimestamp":1741144341,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(9966.HK)盘中一度涨超15%，报6.05港元。消息面上，集团发盈喜，预计2024年度利润不少于1.5亿人民币，首次实现年度盈利，主要基于三项授权合作和销售收入。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05111248531239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2517294930","title":"康宁杰瑞制药绩后大涨！首次实现年度盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294930","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517294930?lang=zh_cn&edition=full","pubTime":"2025-03-05 10:24","pubTimestamp":1741141455,"startTime":"0","endTime":"0","summary":"3月4日，康宁杰瑞制药发布公告称，公司首次实现年度盈利，预期集团在截至2024年12月31日止年度取得利润不少于人民币1.5亿元。再鼎医药近期也发布了2024年度业绩，其总收入为3.990亿美元，同比增长50%；2025年全年收入预期为5.6亿~5.9亿美元。康宁杰瑞制药绩后大涨超10%，领涨恒生医药ETF持仓股，再鼎医药、巨子生物、诺诚健华等涨幅靠前。恒生医药 ETF（159892）跟踪恒生生物科技指数，和AI关联度较高的制药、研发及互联网医疗等板块在持仓中均有覆盖，恒生医药有望持续受益于AI技术革命。恒生医药ETF联接（A类：016970，C类：016971）每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305102702a25fd576&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305102702a25fd576&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2517930297","title":"医药企业即将进入年报窗口，港股创新药ETF涨逾1.6%，康宁杰瑞制药-B涨逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517930297","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517930297?lang=zh_cn&edition=full","pubTime":"2025-03-05 10:12","pubTimestamp":1741140778,"startTime":"0","endTime":"0","summary":"3月5日，港股主要指数高开高走，创新药板块高开震荡。热门ETF中，截至发稿，港股创新药ETF上涨1.64%，成交额超4500万元，换手率超9.6%，开盘后交投活跃。港股创新药ETF紧密跟踪港股通创新药指数，该指数反映港股通生物科技产业上市公司的运行特征。消息面上，近期A股和港股医药企业即将进入年报窗口。多家机构预计年报一季报后医药板块有望迎来行业整体性业绩反转。世纪证券表示，开年以来，创新药个股临床进展和BD消息不断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305102556abe8c00e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305102556abe8c00e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2517937271","title":"港股医药股多数走强 康宁杰瑞制药涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517937271","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517937271?lang=zh_cn&edition=full","pubTime":"2025-03-05 10:01","pubTimestamp":1741140101,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月5日，截至发稿，康宁杰瑞制药-B(09966.HK)涨13.55%、和誉-B(02256.HK)涨8.30%、歌礼制药-B(01672.HK)涨5.97%、腾盛博药-B(02137.HK)涨5.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202503053336964148.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202503053336964148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2517293422","title":"康宁杰瑞制药-B持续上涨逾15% 预期2024年取得利润不少于1.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517293422","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517293422?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:46","pubTimestamp":1741139160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　康宁杰瑞制药-B（09966）发盈喜后持续走高，股价上涨14.70%，现报6.01港元，成交额2727.99万港元。\n　　消息面上，3月4日，康宁杰瑞制药-B发布公告，预期该集团将于截至2024年12 月31日止年度取得利润不少于人民币1.5亿元，而截至2023年12月31日止年度则取得亏损约人民币2.106亿元。此乃公司首次实现年度盈利。\n　　公告称，本公司于报告期内转亏为盈，主要基于三项授权合作和销售收入。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-05/doc-inenqhuv2055858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2517347369","title":"康宁杰瑞制药(09966)涨超12% 公司首次实现年度盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517347369","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517347369?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:41","pubTimestamp":1741138903,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康宁杰瑞制药 股价走高，截至发稿，涨超12%，报5.88港元，成交额1247万港元。。消息面上，3月4日，康宁杰瑞制药发布公告称，公司首次实现年度盈利，预期集团在截至2024年12月31日止年度取得利润不少于人民币1.5亿元，而在截至2023年12月31日止年度取得亏损约人民币2.106亿元。日前，康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体偶联药物JSKN003对比恩美曲妥珠单抗治疗HER2阳性晚期乳腺癌的Ⅲ期临床研究完成首例患者给药。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954363","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2517593260","title":"康宁杰瑞制药-B盘中异动 早盘快速上涨9.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517593260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517593260?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:34","pubTimestamp":1741138495,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时34分，康宁杰瑞制药-B股票出现异动，股价快速上涨9.54%。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，康宁杰瑞制药-B、再鼎医药、科笛-B涨幅较大，振幅较大的相关个股有科笛-B、康宁杰瑞制药-B、同源康医药-B，振幅分别为7.42%、5.53%、4.69%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093455989c58d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093455989c58d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2517931917","title":"港股异动 | 康宁杰瑞制药-B(09966)盈喜高开逾11% 预期首次实现年度盈利 利润不少于1.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517931917","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517931917?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:23","pubTimestamp":1741137825,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康宁杰瑞制药-B(09966)盈喜高开逾11%，截至发稿，涨11.64%，报5.85港元，成交额77.81万港元。消息面上，3月4日，康宁杰瑞制药-B发布公告，预期该集团将于截至2024年12 月31日止年度取得利润不少于人民币1.5亿元，而截至2023年12月31日止年度则取得亏损约人民币2.106亿元。此乃公司首次实现年度盈利。公告称，本公司于报告期内转亏为盈，主要基于三项授权合作和销售收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2517939469","title":"【公司盈喜】康宁杰瑞制药(09966)料2024年同比扭亏为盈至不少于1.5亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2517939469","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517939469?lang=zh_cn&edition=full","pubTime":"2025-03-05 08:57","pubTimestamp":1741136236,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康宁杰瑞制药(09966)公布，预期集团将于截至2024年12月31日止年度录得利润不少于人民币1.5亿元，而截至2023年12月31日止年度则录得亏损约人民币2.11亿元。此乃公司首次实现年度盈利。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/ZjY2YjQxYzhiZWM4YjljOTY5ZWUyMTU0MTAyMDMwNzUxNzY3MzQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZjY2YjQxYzhiZWM4YjljOTY5ZWUyMTU0MTAyMDMwNzUxNzY3MzQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954346","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2517936912","title":"康宁杰瑞制药-B发盈喜 预期首次实现年度盈利2024年利润不少于1.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936912","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517936912?lang=zh_cn&edition=full","pubTime":"2025-03-05 08:34","pubTimestamp":1741134840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　康宁杰瑞制药-B（09966）公布，预期该集团将于截至2024年12 月31日止年度取得利润不少于人民币1.5亿元，而截至2023年12月31日止年度则取得亏损约人民币2.106亿元。此乃公司首次实现年度盈利。\n　　公告称，本公司于报告期内转亏为盈，主要基于三项授权合作和销售收入。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-05/doc-inenqanr9159975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","09966"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":-0.2503},{"period":"1month","weight":0.1448},{"period":"3month","weight":0.8135},{"period":"6month","weight":0.4187},{"period":"1year","weight":0.2458},{"period":"ytd","weight":0.6943}],"compareEarnings":[{"period":"1week","weight":-0.0949},{"period":"1month","weight":-0.1304},{"period":"3month","weight":0.0848},{"period":"6month","weight":-0.0268},{"period":"1year","weight":0.2067},{"period":"ytd","weight":0.031}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家投资控股公司，主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台，包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.121729},{"month":2,"riseRate":0.666667,"avgChangeRate":0.22886},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.028638},{"month":4,"riseRate":0.833333,"avgChangeRate":0.050485},{"month":5,"riseRate":0.4,"avgChangeRate":-0.096701},{"month":6,"riseRate":0.4,"avgChangeRate":0.026634},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0532},{"month":8,"riseRate":0.4,"avgChangeRate":0.041129},{"month":9,"riseRate":0.2,"avgChangeRate":0.094086},{"month":10,"riseRate":0.4,"avgChangeRate":-0.004359},{"month":11,"riseRate":0.6,"avgChangeRate":0.064609},{"month":12,"riseRate":0.6,"avgChangeRate":-0.004095}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}